| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 367.73B | 340.04B | 303.64B | 293.40B | 270.33B | 225.10B |
| Gross Profit | 114.18B | 96.79B | 61.86B | 46.38B | 42.54B | 34.75B |
| EBITDA | 101.39B | 89.25B | 62.46B | 40.39B | 43.00B | 32.20B |
| Net Income | 61.30B | 51.78B | 32.05B | 21.12B | 20.04B | 15.67B |
Balance Sheet | ||||||
| Total Assets | 548.08B | 513.93B | 396.61B | 343.01B | 306.04B | 208.59B |
| Cash, Cash Equivalents and Short-Term Investments | 111.84B | 75.60B | 37.69B | 24.89B | 25.34B | 17.16B |
| Total Debt | 187.35B | 169.84B | 129.99B | 122.83B | 123.18B | 77.30B |
| Total Liabilities | 284.69B | 266.67B | 218.88B | 204.64B | 181.59B | 115.70B |
| Stockholders Equity | 196.62B | 184.01B | 139.79B | 107.51B | 88.94B | 71.03B |
Cash Flow | ||||||
| Free Cash Flow | 59.18B | 44.46B | 24.06B | 6.43B | 3.88B | 5.92B |
| Operating Cash Flow | 90.79B | 74.64B | 48.86B | 36.86B | 28.68B | 26.07B |
| Investing Cash Flow | -36.26B | -31.66B | -32.24B | -33.96B | -50.98B | -23.76B |
| Financing Cash Flow | 1.08B | -10.29B | -4.43B | -5.82B | 27.26B | 23.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$86.12B | 17.50 | 27.52% | 0.54% | 48.74% | 56.71% | |
70 Outperform | HK$104.08B | 27.53 | 11.01% | 0.16% | 56.67% | 139.25% | |
65 Neutral | HK$1.03T | 10.07 | 30.60% | 1.55% | 22.04% | 75.35% | |
64 Neutral | HK$31.46B | 13.75 | 33.81% | 1.40% | 10.57% | 112.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$178.98B | 33.06 | ― | 0.93% | ― | ― |